AstraZeneca Pharma shares gain 3% on CDSCO approval for sale of Tremelimumab
- Hot Stocks
admin
- 0
- 1 minute read
The receipt of this permission paves way for the launch of Tremelimumab solution of 20 mg/ml in India. Tremelimumab, in combination with Durvalumab (Imfinzi), is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC).
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1320976219-73341afb0ad44357b75a2b727609068b.jpg "How Do People Make Money on YouTube?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1149029523-2dc0ce9c456e45d190682b3935d604c4.jpg "Planning for Retirement: 4 Factors to Consider")
:max_bytes(150000):strip_icc():format(jpeg)/computeratwork2-a99e53d3dae94d5ca7c2330b043b56e7.jpg "How Can AI Help Financial Advisors?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1407094529-c87024b05079437a8525d9ced457b2a5.jpg)
" title="